Skip to main content
Skip to main content
HLYK logo

HealthLynked Corp. (HLYK) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$2.13 $0.00 (0.00%) |CouncilSplit View · 40 · C
MCap: $6.27M| Vol: 200| 52-wk range: $1.06 – $6.50

Market cap $6.27M is the value of all shares combined. Beta 2.20: the stock has moved about 120% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

HealthLynked Corp. (HLYK) trades at $2.13. HealthLynked Corp. operates a cloud-based patient information network, connecting patients and healthcare providers through its digital platform. Market cap: $6.27M, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: Mar 15, 2026
HealthLynked Corp. operates a cloud-based patient information network, connecting patients and healthcare providers through its digital platform. The company focuses on streamlining medical data management and offering various healthcare services, including telehealth and medical supply distribution.

Analyst Coverage for HLYK: HLYK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HLYK against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the HLYK film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Council Score · Weighted Average of 3 Disciplines
Split View 40/100 · C

HLYK: 1/2 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Unfavorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

HealthLynked Corp. (HLYK) Healthcare & Pipeline Overview

CEOMichael Thomas Dent
Employees10
HeadquartersNaples, US
IPO Year2017

HealthLynked Corp. provides a cloud-based patient information network and healthcare services, including digital health solutions, ACO/MSO services, and medical distribution. The company aims to streamline medical data management and improve patient-provider communication within the fragmented U.S. healthcare landscape, but faces challenges in scaling its integrated platform.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 15, 2026

What Is the Investment Thesis for HLYK?

AI-written as of Mar 15, 2026 — figures and tone reflect the data available then, not today's score.

HealthLynked Corp. presents a unique investment opportunity within the digital healthcare space, focusing on patient data management and connectivity. With a market capitalization of $6.27M, the company's growth potential hinges on the expansion of its HealthLynked Network and the increasing adoption of its ACO/MSO services. Key value drivers include the ability to attract and retain physician practices within its network and the successful execution of its medical distribution strategy. The company's high gross margin of 97.8% indicates potential for profitability if it can achieve scale. However, the negative P/E ratio of -2.96 and a negative profit margin of -161.5% highlight significant financial challenges. The company's beta of 2.20 suggests high volatility, reflecting the speculative nature of the stock. Successful expansion of its digital healthcare services and effective cost management are critical for realizing its growth potential.

Based on FMP financials and quantitative analysis

HLYK Key Highlights

AI-written as of Mar 15, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $6.27M indicates a micro-cap company with high growth potential but also significant risk.

  • Gross margin of 97.8% suggests a strong pricing power or efficient cost management in its service offerings.
  • Negative P/E ratio of -2.96 reflects current unprofitability, indicating a need for improved operational efficiency or revenue growth.
  • Beta of 2.20 indicates high volatility compared to the market, suggesting a speculative investment.
  • Operates in four divisions: Health Services, Digital HealthCare, ACO/MSO, and Medical Distribution, providing diversified revenue streams but also operational complexity.

Who Are HLYK's Competitors?

HLYK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AMS American Shared Hospital Services $1.48 +0.68% $9.80M 465-pillar
PIII P3 Health Partners Inc. $8.36 -0.71% $27.4M
CCEL Cryo-Cell International, Inc. $4.13 +0.49% $33.3M 315-pillar
DCGO DocGo Inc. $0.35 -3.53% $34.8M
BTMD biote Corp. $1.31 -9.66% $57.8M 665-pillar
CCM Concord Medical Services Holdings Limited $3.95 -4.13%
JYNT The Joint Corp. $7.85 -2.24% $112M 705-pillar
AIRS AirSculpt Technologies, Inc. $2.48 +3.13% $175M 335-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HLYK's Key Strengths?

Integrated platform offering a range of healthcare services.

  • Cloud-based patient information network for efficient data management.
  • High gross margin of 97.8% indicating strong pricing power.
  • Diverse revenue streams across four divisions.

What Are HLYK's Weaknesses?

Negative P/E ratio and profit margin indicating current unprofitability.

  • Small market capitalization and limited financial resources.
  • High beta indicating high volatility and speculative nature.
  • Dependence on attracting and retaining physician practices.

What Could Drive HLYK Stock Higher?

Expansion of the HealthLynked Network to include more patients and providers.

  • Growth in ACO/MSO services due to increasing adoption of value-based care.
  • Expansion of the medical distribution division to offer a wider range of products.
  • Potential strategic partnerships or acquisitions to expand capabilities and market reach.
  • Expansion of telehealth services to provide remote consultations and monitoring to patients.

What Are the Key Risks for HLYK?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

  • Intense competition from larger, more established players in the digital health market.
  • Regulatory changes and healthcare reform impacting the ACO/MSO business.
  • Cybersecurity risks and data breaches compromising patient data.
  • Economic downturn impacting patient spending on healthcare services.
  • Limited liquidity due to low trading volume on the OTC market.

What Are the Growth Opportunities for HLYK?

  • Expansion of the HealthLynked Network: The company can grow by expanding its HealthLynked Network to include more patients and providers. Timeline: Ongoing, with continuous efforts to onboard new users and integrate with existing healthcare systems.
  • Growth in ACO/MSO Services: The increasing adoption of value-based care models and the Medicare Shared Savings Program presents a growth opportunity for HealthLynked's ACO/MSO division. The ACO market is expected to reach $60 billion by 2027. Timeline: Ongoing, with continuous efforts to expand its ACO/MSO services to more physician practices.
  • Medical Distribution Division Expansion: The company can expand its medical distribution division by offering a wider range of discounted medical supplies to consumers and medical practices. The global medical supplies market is projected to reach $170 billion by 2028. Timeline: Ongoing, with continuous efforts to expand its product offerings and distribution channels.
  • Strategic Partnerships and Acquisitions: HealthLynked can pursue strategic partnerships or acquisitions to expand its capabilities and market reach. This could include partnerships with other digital health companies, healthcare providers, or technology companies. Timeline: Potential, with ongoing evaluation of potential partnership and acquisition opportunities.
  • Telehealth Services Expansion: HealthLynked can expand its telehealth services to provide remote consultations and monitoring to patients. The telehealth market is expected to reach $175 billion by 2026, driven by increasing demand for remote healthcare services. Timeline: Ongoing, with continuous efforts to expand its telehealth offerings and integrate them into its HealthLynked Network.

What Are HLYK's Competitive Advantages?

  • Network effect: The HealthLynked Network becomes more valuable as more patients and providers join the platform.
  • Integrated platform: The company offers a comprehensive suite of services, including patient data management, healthcare services, and medical distribution.
  • Proprietary technology: The company's cloud-based platform and record archiving system provide a competitive advantage.

What Does HLYK Do?

HealthLynked Corp., incorporated in 2014 and headquartered in Naples, Florida, operates a cloud-based patient information network and record archiving system in the United States. The company's mission is to connect patients and healthcare providers through its digital platform, aiming to streamline medical data management and improve communication. HealthLynked operates through four divisions: Health Services, Digital HealthCare, Accountable Care Organization/Managed Service Organization (ACO/MSO), and Medical Distribution. The Health Services division offers obstetrical and gynecological medical services, functional medicine focusing on neurodegenerative diseases, and physical therapy through Bridging the Gap Physical Therapy. The Digital HealthCare division operates the HealthLynked Network, enabling patients and doctors to manage medical information via a cloud-based system. This segment also provides online scheduling for appointments. The ACO/MSO division assists physician practices in providing care through the Medicare Shared Savings Program and offers consulting services to healthcare providers and ACOs. The Medical Distribution Division functions as a virtual distributor of discounted medical supplies to consumers and medical practices. HealthLynked aims to create a comprehensive healthcare ecosystem, but faces competition from larger, more established players in the digital health and healthcare services markets.

What Products and Services Does HLYK Offer?

  • Operates a cloud-based patient information network.
  • Provides a record archiving system for medical data.
  • Offers obstetrical and gynecological medical services.
  • Provides functional medicine focusing on neurodegenerative diseases.
  • Offers physical therapy services through Bridging the Gap Physical Therapy.
  • Operates an ACO and MSO to assist physician practices in providing care.
  • Functions as a virtual distributor of discounted medical supplies.

How Does HLYK Make Money?

  • Generates revenue from Health Services division through patient care and medical procedures.
  • Earns revenue from Digital HealthCare division through subscriptions and licensing fees for the HealthLynked Network.
  • Receives revenue from ACO/MSO division through consulting services and shared savings programs.
  • Generates revenue from Medical Distribution division through the sale of discounted medical supplies.

What Industry Does HLYK Operate In?

HealthLynked Corp. operates within the rapidly evolving digital health market, which is experiencing significant growth due to increasing adoption of telehealth, electronic health records, and remote patient monitoring. The industry is characterized by intense competition, with established players like Cerner and Allscripts, as well as numerous startups vying for market share. HealthLynked's focus on patient data management and connectivity positions it within the broader trend of value-based care and personalized medicine. The company's success depends on its ability to differentiate itself through its integrated platform and attract a critical mass of patients and providers.

Who Are HLYK's Key Customers?

  • Patients seeking medical care and access to their medical records.
  • Physician practices looking to improve patient care and participate in shared savings programs.
  • Healthcare providers seeking consulting services for ACO/MSO operations.
  • Consumers and medical practices purchasing discounted medical supplies.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 15, 2026

Research confidence

Medium 45/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 28 days ago
  • No analyst coverage

MoonshotScore History

Recorded daily since 2026-08-23 · 20 snapshots

2026-08-23 46
2026-08-27 46
2026-08-31 46
2026-09-04 46
2026-09-08 46
2026-09-11 46

What changed?

The score has stayed at 46.

Over the same 19 days the stock moved -22.4%.

Company Profile

HealthLynked Corp. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Naples, US. The company is led by CEO Michael Thomas Dent. HLYK has traded publicly since 2017.

HealthLynked Corp. Financial Trajectory

HealthLynked Corp. (HLYK) reported $250K in revenue for Q2 FY2026, a decline of 41.0% compared to the prior quarter. The company recorded a net loss of $820K, with diluted EPS of $-0.28. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, HLYK averaged $-0.34 in diluted EPS.

How HealthLynked Corp. Is Valued

HealthLynked Corp. carries a market capitalization of $6.27M, placing it in the micro-cap category.

ROE 61%

Key Financial Metrics

Return on equity for HealthLynked Corp. stands at 61.1%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -31.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.17 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -54.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 3/9

Financial Health

HealthLynked Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

Net buying

Insider Activity

The most recent 11 insider filings for HealthLynked Corp. break down as 0 sales and 11 purchases. On net that is roughly 10.7M shares acquired (about $721K) — insiders putting money in tends to read as conviction.

HLYK Financials

Fundamental Snapshot

Revenue Growth (FY)
-31.3%
Net Income Growth (FY)
+46.5%
EPS Growth (FY)
+46.8%
Free Cash Flow Growth (FY)
+51.0%
Return on Equity (TTM)
+61.1%
Current Ratio
0.2

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Integrated platform offering a range of healthcare services.
  • Cloud-based patient information network for efficient data management.
  • High gross margin of 97.8% indicating strong pricing power.
  • Diverse revenue streams across four divisions.

Bear Case

  • Negative P/E ratio and profit margin indicating current unprofitability.
  • Small market capitalization and limited financial resources.
  • High beta indicating high volatility and speculative nature.
  • Dependence on attracting and retaining physician practices.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $249,830 -$819,705 -$0.28
Q1 FY2026 $423,465 -$2M -$0.56
Q4 FY2025 $310,179 -$676,477 -$0.24
Q3 FY2025 $388,545 -$851,800 -$0.30

Q2 FY2026 · filed 14 Aug 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

HLYK Latest News

HLYK Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HLYK.

Price Targets

Wall Street price target analysis for HLYK.

HLYK MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for HLYK; grades run from A+ (80-100) to F (below 30).

Leadership: Michael Thomas Dent

CEO

Michael Thomas Dent serves as the CEO of HealthLynked Corp. His background includes experience in managing and growing healthcare-related businesses. He is responsible for the overall strategic direction and operational execution of the company. His leadership focuses on expanding HealthLynked's digital platform and healthcare service offerings. He oversees the company's four divisions and is involved in key decisions related to partnerships, acquisitions, and product development. He manages a team of approximately 20 employees.

Track Record: Under Michael Thomas Dent's leadership, HealthLynked has focused on expanding its HealthLynked Network and developing its ACO/MSO services. Key milestones include the growth of the company's digital platform and the expansion of its medical distribution division. He has focused on integrating the company's various divisions to create a comprehensive healthcare ecosystem. However, the company's financial performance remains a challenge, with ongoing efforts to achieve profitability.

HLYK OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that HealthLynked Corp. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors and may be subject to greater risks. Unlike companies listed on the NYSE or NASDAQ, OTC Other companies do not have to adhere to stringent listing standards, resulting in less regulatory oversight and potentially higher information asymmetry.

  • OTC Tier: OTC Other
Liquidity: As an OTC stock, HealthLynked's liquidity may be limited. Trading volume can be low, leading to wider bid-ask spreads and difficulty in executing large trades without significantly impacting the stock price. Investors should carefully assess the trading volume and bid-ask spread before investing to avoid potential difficulties in buying or selling shares.
OTC Risk Factors:
  • Limited liquidity due to low trading volume.
  • Lack of regulatory oversight compared to NYSE or NASDAQ-listed companies.
  • Potential for information asymmetry due to limited financial reporting.
  • Higher risk of fraud or manipulation compared to regulated exchanges.
  • Volatility due to speculative trading and limited institutional investment.
Due Diligence Checklist:
  • Verify the company's financial statements and reporting frequency.
  • Assess the trading volume and bid-ask spread to evaluate liquidity.
  • Research the company's management team and their track record.
  • Review the company's business model and competitive landscape.
  • Consult with a financial advisor to assess the risks and suitability of the investment.
  • Check for any regulatory actions or legal issues involving the company.
  • Confirm the company's contact information and physical address.
Legitimacy Signals:
  • Operation since 2014 suggests some business viability.
  • Presence of four distinct operating divisions indicates diversification.
  • Focus on digital healthcare aligns with industry trends.
  • CEO with experience in healthcare management.
  • Headquarters located in Naples, Florida.

Common Questions About HLYK (Healthcare)

Is HLYK a good stock?

Stock Expert AI does not rate HLYK buy, sell or hold. HealthLynked Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about HLYK stock?

Key valuation metrics to consider include the company's market capitalization, P/E ratio, profit margin, and gross margin. Investors should also consider the company's growth potential, competitive landscape, and risk factors. The company's high beta suggests high volatility, reflecting the speculative nature of the stock. Further analysis is needed to assess the company's long-term prospects and potential for value creation.

What are the key factors to evaluate for HLYK?

Evaluate HLYK on fundamentals, analyst consensus, and risk factors. The company's high gross margin of 97.8% indicates potential for profitability if it can achieve scale. Not financial advice.

How frequently does HLYK data refresh on this page?

HLYK's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 calculations are scheduled daily at 10:15 UTC; the score's own date shows its last successful run.

What has driven HLYK's recent stock price performance?

HealthLynked Corp. (HLYK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated platform offering a range of healthcare services. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider HLYK overvalued or undervalued right now?

HealthLynked Corp. (HLYK) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of HLYK?

Yes, most major brokerages offer fractional shares of HealthLynked Corp. (HLYK) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track HLYK's earnings and financial reports?

HealthLynked Corp. (HLYK) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for HLYK earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • The analysis is based on publicly available information and may not reflect all relevant factors.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover